Home  |  Contact

UniProtKB/Swiss-Prot Q9H2X0: Variant p.Met630Leu

Chordin
Gene: CHRD
Variant information

Variant position:  630
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Methionine (M) to Leucine (L) at position 630 (M630L, p.Met630Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  630
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  955
The length of the canonical sequence.

Location on the sequence:   VVKDLEPELLRHLAKGMASL  M ITTKGSPRGELRGQVHIANQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VVKDLEPELLRHLAKGMASLMITTKGSPRGELRGQVHIANQ

Mouse                         VVKDLEPVLLRHLAQGTASLLITTKSSPRGELRGQVHIASQ

Rat                           VVKDLEPVLLRHLTQGTASLLITTKSNPRGELRGQVHIASQ

Xenopus laevis                SVKDLDLELLGHLSRGTAFIQVSTKLNPRGEIRGQIHIPNS

Zebrafish                     VLKDISVELLRHLNEGTAYLQVSTKMNPRGEIRGRIHVPNH

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 27 – 955 Chordin
Domain 530 – 650 CHRD 4
Alternative sequence 87 – 955 Missing. In isoform 2.
Alternative sequence 95 – 955 Missing. In isoform 3.
Alternative sequence 351 – 955 Missing. In isoform 4.


Literature citations

The human chordin gene encodes several differentially expressed spliced variants with distinct BMP opposing activities.
Millet C.; Lemaire P.; Orsetti B.; Guglielmi P.; Francois V.;
Mech. Dev. 106:85-96(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4); VARIANT LEU-630;

Coding sequence and expression patterns of mouse chordin and mapping of the cognate mouse chrd and human CHRD genes.
Pappano W.N.; Scott I.C.; Clark T.G.; Eddy R.L.; Shows T.B.; Greenspan D.S.;
Genomics 52:236-239(1998)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 115-955 (ISOFORM 5); VARIANT LEU-630;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.